Disease progression in pediatric multiple sclerosis: Disparities between physical and neurocognitive outcomes

Expert Review of Neurotherapeutics

Volumn 11, Issue 3, 2011, Pages 433-440

  Yeh, Eluen Ann ^a,b   Parrish, Joy B ^a,b   Weinstock Guttman, Bianca ^a,b  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

adolescent; cognition; demyelinating disease; disease progression; MRI; multiple sclerosis; neurocognitive testing; pediatric; quality of life

Indexed keywords

BETA1A INTERFERON; FINGOLIMOD; GLATIRAMER; INTERFERON BETA SERINE; MITOXANTRONE; NATALIZUMAB;

APTITUDE TEST; CHILDHOOD DISEASE; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; LONGITUDINAL STUDY; MENTAL DETERIORATION; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; QUALITY OF LIFE; REVIEW;

ADOLESCENT; BRAIN; CHILD; COGNITION; COGNITION DISORDERS; DISABLED PERSONS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952692182     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.192     Document Type: Review

References (65)

1. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult. Scler. 15(5), 627-631 (2009)
2. Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: a longitudinal study. Neurology 59(7), 1006-1010 (2002)
3. Simone IL, Carrara D, Tortorella C et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 59(12), 1922-1928 (2002)
4. Kennedy J, O'Connor P, Sadovnick AD, Perara M, Yee I, Banwell B. Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology 26(3), 162-167 (2006)
5. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7(12), 1139-1151 (2008)
6. Mikaeloff Y, Adamsbaum C, Husson B et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127(Pt 9), 1942-1947 (2004)
7. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur. J. Paediatr. Neurol. 11(2), 90-95 (2007)
8. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68(16 Suppl. 2), S7-S12 (2007)
9. Hahn CD, Shroff MM, Blaser SI, Banwell BL. MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology 62(5), 806-808 (2004)
10. Callen DJ, Shroff MM, Branson HM et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 72(11), 968-973 (2009)
11. Callen DJ, Shroff MM, Branson HM et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology 72(11), 961-967 (2009)
12. Neuteboom RF, Boon M, Catsman Berrevoets CE et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 71(13), 967-973 (2008)
13. Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology 74(18), 1412-1415 (2010)
14. Waubant E, Chabas D, Okuda DT et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch. Neurol. 66(8), 967-971 (2009)
15. Yeh EA, Weinstock-Guttman B, Ramanathan M et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain 132(Pt 12), 3392-3400 (2009)
16. Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J. Neuroimaging 14, S27-S35 (2004)
17. Mesaros S, Rocca MA, Absinta M et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 70(13 Pt 2), 1107-1112 (2008)
18. Rocca MA, Absinta M, Ghezzi A, Moiola L, Comi G, Filippi M. Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients? Hum. Brain Mapp. 30(9), 2844-2851 (2008)
19. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch. Neurol. 66(1), 54-59 (2009)
20. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM. Multiple sclerosis in children under 6 years of age. Neurology 53(3), 478-484 (1999)
21. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13(3), 227-231 (1983)
22. Renoux C, Vukusic S, Mikaeloff Y et al. Natural history of multiple sclerosis with childhood onset. N. Engl. J. Med. 356(25), 2603-2613 (2007)
23. Tortorella P, Rocca MA, Mezzapesa DM et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J. Neurol. 253(7), 903-907 (2006)
24. Rocca MA, Absinta M, Moiola L et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology 254(2), 541-550 (2010)
25. Giedd JN, Blumenthal J, Jeffries NO et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 2(10), 861-863 (1999)
26. Sowell ER, Trauner DA, Gamst A, Jernigan TL. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev. Med. Child Neurol. 44(1), 4-16 (2002)
27. Anderson V, Spencer-Smith M, Leventer R et al. Childhood brain insult: can age at insult help us predict outcome? Brain 132(Pt 1), 45-56 (2009)
28. Rocca MA, Absinta M, Valsasina P et al. Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. Hum. Brain Mapp. 30(8), 2412-2425 (2008)
29. Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 70(20), 1891-1897 (2008)
30. Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology 64(5), 891-894 (2005)
31. Wechsler D. Wechsler Abbreviated Scale of Intelligence. Pearson, Inc., TX, USA (1999)
32. Beery K, Beery N. The Beery-Buktenica Developmental Test of Visual-Motor Integration. Pearson, Inc., TX, USA (2006)
33. Martin N. Test of Visual Perceptual Skills. PAR, Inc., FL, USA (2006)
34. Matthews CG, Klove K. Instruction Manual for the Adult Neuropsychology Test Battery. University of Wisconsin Medical School, WI, USA (1964)
35. Delis DC, Kramer J. California Verbal Learning Test - Childrens Version. The Psychological Corporation, TX, USA (1994)
36. Benedict RHB. Brief Visuospatial Memory Test - Revised. Psychological Assessment Resources, FL, USA (1997)
37. Brownell R. Expressive One-Word Picture Vocabulary Test. Academic Therapy Publications, CA, USA (2000)
38. Delis DC, Kaplan E. Delis-Kaplan Executive Function System. The Psychological Corporation, TX, USA (2001)
39. Conners KC. Conners Continuous Performance Test II. Multi-Health Systems, NY, USA (2000)
40. Anderson PE, Anderson V. Standardization of the Contingency Naming Test (CNT) for school-aged children: a measure of reactive flexibility. Clin. Neuropsychol. Assess. 1, 247-273 (2000)
41. McGrew KS, Woodcock RW. Technical Manual: Woodcock-Johnson III. Riverside Publishing, IL, USA (2001)
42. Wechsler D. Wechler Individual Achievement Test, Second Edition. The Psychological Corp., A Harcourt Assessment Company, TX, USA (2002)
43. Varni J, Seid M, Kurtin P. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 generic core scales in healthy and patient populations. Med. Care 39, 800-812 (2001)
44. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Psychological Assessment Resources Inc., FL, USA (2000)
45. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41(5), 685-691 (1991)
46. Pelosi L, Geesken JM, Holly M, Hayward M, Blumhardt LD. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain 120(Pt 11), 2039-2058 (1997)
47. Piras MR, Magnano I, Canu ED et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J. Neurol. Neurosurg. Psychiatry 74(7), 878-885 (2003)
48. MacAllister WS, Belman AL, Milazzo M et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 64(8), 1422-1425 (2005)
49. MacAllister WS, Christodoulou C, Milazzo M, Krupp LB. Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev. Neuropsychol. 32(2), 625-644 (2007)
50. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch. Neurol. 52(2), 168-172 (1995)
51. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch. Neurol. 58(10), 1602-1606 (2001)
52. Amato M, Gordetti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS: a reappraisal after 2 years. Neurology 72(Suppl. 1), A97 (2009)
53. MacAllister WS, Christodoulou C, Troxell R et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult. Scler. 15(12), 1502-1508 (2009)
54. Mowry E, Julian L, Chabas D et al. Health-related qulaity of life is reduced in children with early multiple sclerosis. Mult. Scler. 14(Suppl. 1), S147 (2008)
55. Pohl D, Rostasy K, Gartner J, Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon b-1a. Neurology 64(5), 888-890 (2005)
56. Ghezzi A. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study. Neurol. Sci. 26(Suppl. 4), S183-S186 (2005)
57. Banwell B, Reder AT, Krupp L et al. Safety and tolerability of interferon b-1b in pediatric multiple sclerosis. Neurology 66(4), 472-476 (2006)
58. Ghezzi A, Amato MP, Capobianco M et al. Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult. Scler. 11(4), 420-424 (2005)
59. Waubant E, Hietpas J, Stewart T et al. Interferon b-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 32(4), 211-213 (2001)
60. Fischer JS, Priore RL, Jacobs LD et al. Neuropsychological effects of interferon b-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann. Neurol. 48(6), 885-892 (2000)
61. Barak Y, Achiron A. Effect of interferon-b-1b on cognitive functions in multiple sclerosis. Eur. Neurol. 47(1), 11-14 (2002)
62. Kappos L, Freedman MS, Polman CH et al. Long-term effect of early treatment with interferon b-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the Phase 3 BENEFIT trial. Lancet Neurol. 8(11), 987-997 (2009)
63. Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch. Neurol. 56(3), 319-324 (1999)
64. Cernich AN, Kurtz SM, Mordecai KL, Ryan PB. Cognitive rehabilitation in traumatic brain injury. Curr. Treat. Options Neurol. 12(5), 412-423 (2010)
65. Portaccio E, Goretti B, Zipoli V et al. Cognitive rehabilitation in children and adolescents with multiple sclerosis. Neurol. Sci. 31(Suppl. 2), S275-S278 (2010)